In today’s issue: The escalating battle against the abortion pill. … Two new additions to an influential vaccine advisory ...

Eli Lilly (LLY) says its weight-loss pill is on track to be approved in the US, lagging behind Novo Nordisk (NVO). Eli Lilly ...

WELL, NEW AT NOON A CALIFORNIA DOCTOR IS BEING CHARGED HERE IN LOUISIANA FOR HIS ALLEGED ROLE IN ALLEGEDLY TRAFFICKING ...

Gov. Larry Rhoden asked lawmakers on Tuesday to pass legislation that would stop the delivery of medication into the state ...

Novo Nordisk A/S (NOVO:CA) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 12:45 PM ESTCompany ...

Louisiana has indicted a California physician with allegedly sending abortion pills to the state and is seeking his return to ...

Louisiana Attorney General Liz Murrill has indicted a California doctor on felony charges tied to mailing abortion pills into ...

Louisiana Attorney General Liz Murrill has sent an extradition request to prosecute a California doctor accused of violating the state's abortion pill law.

Novo Nordisk CEO Mike Doustdar said on Tuesday the drugmaker expects headwinds in its international operations in 2026, as ...

Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...

SHE LEARNED ABOUT UMPIRING AND BEING A GOALIE DAD AND THE STOMACH CRAMP HE SOMETIMES FELT WHEN HE WAS STRESSED. I SAW A ...

Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said on Monday, a larger percentage than the company originally anticipated.